![Douangsone Vadysirisack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Douangsone Vadysirisack currently works at Ra Pharmaceuticals, Inc., as Director-Biology.
Dr. Vadysirisack also formerly worked at Dianthus Therapeutics, Inc., as Vice President-Translational Biology in 2023.
Dr. Vadysirisack received his doctorate degree from The Ohio State University.
Anciens postes connus de Douangsone Vadysirisack
| Sociétés | Poste | Fin |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2023 |
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Douangsone Vadysirisack
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
